Quintiles names ex-EMA lead chief of risk management
This article was originally published in Scrip
Executive Summary
Biopharmaceutical development and commercial outsourcing service provider Quintiles has named Dr Stella Blackburn vice-president and global head of risk management for its real-world and late phase research group. Dr Blackburn will be responsible for leading the group's risk management efforts in North America, EU and Asia-Pacific. Dr Blackburn joins the North Carolina-based company from the European Medicines Agency, where most recently she was the EMA risk management development and scientific lead. In this role Dr Blackburn was responsible for designing and implementing risk management public policy and processes used throughout Europe.